PMC7332806_01
Summary of outcome measures
EXCLI-19-745-t-001.jpg
PMC7332806_01_EXCLI-19-745-t-001.jpg
T1
The PAS scores for liquids and solids were 8 and 2, respectively (Figure 1(Fig. 1)).
Baseline FEES showed a silent aspiration and moderate residues at both, the pyriform sinuses and vallecula for liquids.
EXCLI-19-745-g-001.jpg
PMC7332806_01_EXCLI-19-745-g-001.jpg
F1
The patient received anodal tDCS and Conventional Dysphagia Therapy (CDT) simultaneously for ten 30-minute sessions (twice daily for five days over two weeks) (Figure 2(Fig. 2)).
Treatment, and evaluation protocol. The patient received the combined treatment (Anodal tDCS, and conventional dysphagia treatment) for 5 days over two weeks, and was evaluated three times. Swallowing Disturbance Questionnaire (SDQ), Dysphagia Handicap Index (DHI) and Fiberoptic endoscopic evaluation of swallowing (FEES) were assessed at baseline, immediately after the last session, and one month after treatment.
EXCLI-19-745-g-002.jpg
PMC7332806_01_EXCLI-19-745-g-002.jpg
F2
The return electrode was placed above the central supraorbital area (Fpz) (Figure 3(Fig. 3)). tDCS was applied twice daily with a 20 min interval in between for five days over two weeks.